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to evaluate a single capacity (e.g., consenting to medical treatment, managing finances), while other
areas important to the evaluation of DMC received little attention (e.g., activities of daily living, the
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Abstract
Decision-making capacity (DMC) in aging adults has become increasingly salient as the number of older adults, life
expectancy, and the amount of wealth to be transferred from older generations have all increased. The accurate
and reliable determination of older adults’ DMC is a particularly important topic given its implication in legal,
financial, and health decisions. Based upon the four-ability DMC model promulgated by Appelbaum and Grisso in
the 1980’s, a number of MacArthur Competence Assessment Tools have been developed and widely utilized.
However, these tools do not include cognitive testing or other sources of objective data and have limited validity
in a medico-legal setting, necessitating additional options for the evaluation of DMC. This is significant from the
perspective of the patient because they have a vested interest in accurate and objective assessment of their DMC
across domains.
Given the disparities in the assessment of DMC, the authors propose, through this debate article, that the
evaluation of DMC in the aging adult population utilize a combination of traditional interview and domain specific
instruments and neuropsychological testing. To achieve a consensus on the issue, medical experts in a number of
fields related to capacity evaluation, including psychiatry, neurology, neuropsychology, and general medicine were
consulted and recruited as authors. Experts in Swiss law and ethics were also consulted and provided input.
A tendency to focus on a single capacity, and in particular, the ability to consent to medical treatment, arose in the
literature. Similarly, there are many instruments purporting to evaluate a single capacity (e.g., consenting to medical
treatment, managing finances), while other areas important to the evaluation of DMC received little attention (e.g.,
activities of daily living, the ability to live independently, to marry, to resist undue influence, and to make a will or
advanced care directive). Medical and legal experts in the multidisciplinary group agreed that there is a clear need
for more consistency across evaluation of DMC domains and that a combined approach of traditional methods and
neuropsychological testing provides a more thorough evaluation and better serves the patient.
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Background
The issue of DMC evaluation has become increasingly
relevant and will continue to gain importance as the
world’s aging population and the number of people with
dementia both increase. According to the World Health
Organization, around 50 million people are affected by
dementia and it was recently recognized as an inter-
national public health priority which spurred the cre-
ation of a Global Action Plan [1]. With an increased
aging population comes an increase in disability, poten-
tial for financial and personal abuse, and need for sup-
port. The evaluation of older adults’ DMC is a
particularly important topic given the significant legal, fi-
nancial, and health ramifications. Additionally, the mod-
ern view of Advance Care Planning (ACP) is that of “a
continuous, dynamic process of reflection and dialogue
between an individual, those close to them, and their
healthcare professionals” [2]. As such, it can be argued
that DMC will not only need to be evaluated on a case-
by-case basis, but repetitively in the course of a progres-
sive dementia [2].
At present, there are limited standardized means for
clinicians to evaluate an individual’s capacity to make
important life decisions such as executing a will, con-
senting to medical treatment, or engaging in financial
or highly personal contracts. Research to date has
generally been domain-specific, including financial
capacity [3], testamentary capacity, and consent for
medical treatment. Several evaluation instruments
have been developed to evaluate these specific do-
mains of interest, such as the MacArthur Competence
Assessment Tool for Treatment (MacCAT-T) [3], but
are not entirely consistent with each other and do
not generalize beyond a single capacity. Although it is
agreed that development of a global “capacimeter” as
described in the 1990’s [4] is too far-reaching, an in-
crease in standardization of civil capacity evaluation
could assist in the collaboration between professions
[5] and provide better patient care overall.
In addition to psychiatrists and clinical psychologists,
neuropsychologists are increasingly being consulted in
medico-legal settings, including cases involving civil
DMC [5]. The significant contribution neuropsycho-
logical assessment can make in this context has been
highlighted in recent years, both in specific domains
such as testamentary capacity, [6] and more broadly [7].
Neuropsychological performance, defined here as stan-
dardized scores obtained on measures of cognitive func-
tioning, has been shown to strongly relate to current
and future DMC and neuropsychologists are particularly
equipped to assist in identifying which of the relevant
areas may be impaired [8]. Accordingly, there is “a crit-
ical need for decision-making science to inform the de-
sign of capacity measures to reflect the multiple
neuropsychological processes contributing to these deci-
sions” [8 p274].
Additionally, recent research has identified cognitive
impairment as the biggest challenge for physicians who
have to evaluate DMC [9]. The majority of DMC evalua-
tions concerns older adults and, importantly, psychia-
trists and other medical health providers judge their
training in capacity evaluation as insufficient [9]. Ac-
cording to the American Psychiatric Association’s Diag-
nostic and Statistical Manual of Mental Disorders,
neurocognitive impairment is divided into mild and
major, both of which require evidence of cognitive de-
cline (modest for mild and significant for major) and
may be attributed to Alzheimer’s, Parkinson’s, or cere-
brovascular disease, a traumatic brain injury, frontotem-
poral lobar degeneration, dementia with Lewy Bodies, or
other etiologies, but major neurocognitive disorders
interfere with an individual’s ability to independently
complete activities of daily living [10]. In a literature re-
view on patient characteristics associated with decisional
incapacity, persons with Alzheimer’s Disease (categoric-
ally separate from Mild Cognitive Impairment) were
found to lack DMC over half (54%) of the time [11],
underscoring the importance of DMC evaluation in the
aging population.
Construction and content
Aside from clinical interviews, numerous tools have been
created to evaluate explicit capacities, albeit with differ-
ing approaches. With respect to specific DMCs, we
found in a review of recent literature that the DMC to
consent to medical treatment received the greatest atten-
tion. It was also the impetus for development of Appel-
baum and Grisso’s four-ability model involving the
abilities a) to understand information relevant to the de-
cision, b) to appreciate the situation and the likely con-
sequences of the available options, c) to reason and
weigh the options against each other, based on one’s
own values, and d) to make and communicate a choice
[12, 13]. Interestingly, despite its wide acceptance across
the world, the four-ability model has little support for
use in forensic (medico-legal) settings [14], and it had
been widely criticized for not focusing more on emo-
tions and values [15]. Nonetheless, it remains the basis
for many evaluation measures, including the MacCAT-T
and the MacArthur Competence Assessment Tool for
Clinical Research (MacCAT-CR). In addition to the
MacCAT-T, recent research has documented 19 separ-
ate instruments just for the evaluation of DMC to con-
sent to treatment, many of which had limited criterion
validity and inter-rater reliability [16]. In 1977, Roth and
colleagues suggested the most useful tools for DMC
evaluation would be those that can be reliably applied,
are accepted by more than one discipline, adequately
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balance autonomy with the need for treatment, and use
objective rather than inferred or subjective means [13].
The field of neuropsychology can provide helpful assess-
ments of certain cognitive aspects of DMC that can be
used as part of a multidisciplinary evaluation, particu-
larly as research has shown that DMC correlates more
strongly with cognitive functioning than with psychiatric
functioning [7].
In Switzerland, a recent survey indicated that most
participating physicians only use unstructured clinical
interviews to evaluate medical DMC [17]. Thereafter, a
two-page DMC interview guide termed U-Doc [18] was
developed based upon the four-ability model and
adopted by the Swiss Academy of Medical Sciences in
their 2018 guidelines on the evaluation of DMC [19].
The instrument does not comprise mandatory neuro-
psychological testing but emphasizes that it can be in-
cluded in the evaluation procedure if necessary.
In health care, it is often the case that the treating phys-
ician is both the professional questioning a patient’s DMC
and subsequently evaluating it. While some scholars cite the
longstanding doctor-patient relationship and the primary
physician’s knowledge of the patient’s history as important in
a DMC evaluation [20], this approach tends to overestimate
a patient’s DMC with low inter-rater reliability [21], and cre-
ates a dual role that could lead to conflicts of interest and
violation of ethical standards for professional conduct [22].
While the dual role has the advantage of knowledge of the
patient over time, presumably with an inherent internal
measure of proportionality, low inter-rater reliability among
health care professionals is something that has plagued
DMC evaluation in general, whether the evaluators are com-
pared with each other or with experts in the field [16, 23].
Additionally, there is limited consistency in how profes-
sionals evaluate DMC, and low agreement between subject-
ive impressions of DMC and standardized evaluation
procedures [24].
The lack of inter-rater reliability appears to be linked to
the inherently value-laden nature of capacity assessments.
Ethicists have cautioned that capacity evaluation is never fully
neutral and that the personal values of the evaluators play a
major role and should be considered [24]. Evaluations should
be functional and specific to the decision at hand rather than
a global determination because DMC may fluctuate and the
requisite level of abilities depend on the complexity of the
decision [24]. While it cannot be said that neuropsycho-
logical evaluations are not influenced to some degree by the
evaluator, they can offer objective data that go beyond sub-
ject patient answers on given questions or mapping a pa-
tient’s response onto a particular aspect of DMC.
Utility and discussion
The authors propose using a combination of traditional
DMC assessment methods typically utilized by primary
care physicians and attorneys, such as interviews and
tools designed for specific capacities, with neuropsycho-
logical evaluation. This is particularly important in com-
plicated cases and in cases where an individual’s
underlying cognitive abilities are not well-known. As an
example, the American Bar Association and the Ameri-
can Psychological Association took the stance many
years ago that an evaluation of an individual’s capacity
to carry out activities of daily living must include an as-
sessment of the underlying cognitive and judgment skills
to be sufficient [25]. Cognitive impairment related to de-
mentia is the most common threat to living independ-
ently for adults and an evaluation of the capacity to live
independently should include measures of attention and
orientation, episodic memory, executive functioning, and
language skills, which are considered to be the cognitive
underpinnings of this capacity [25]. This connection is
not limited to activities of daily living either. Specific
cognitive domains are considered to underly the capacity
to create and execute a will, including semantic know-
ledge, autobiographical memory, recent memory, work-
ing memory and other executive functions, as well as
language [6, 14]. An interdisciplinary team approach in-
volving a patient’s physicians and specialists, their attor-
ney, and a neuropsychologist would allow for the most
thorough and ethical evaluation of a patient’s DMC
whereby a neuropsychologist can assess underlying skills
and provide information as to how any limitations might
impact a patient’s DMC in medicolegal settings. This
would provide physicians, including specialists such as
neurologists, and attorneys with critical information to
use in making DMC determinations.
Importantly, a neurocognitive model of medical DMC
has been proffered as the best way to understand this
particular capacity in an aging population with memory
impairments. The model is based upon three core cogni-
tive tasks involved in a patient’s determination of treat-
ment preferences, including “(a) comprehension,
encoding and retrieval of treatment information; (b) in-
formation processing and internally arriving at a treat-
ment decision; and (c) verbal or written communication
of the treatment decision” [26 p223]. The authors
suggest administering measures of receptive language,
short-term memory, executive functioning, and judg-
ment/reasoning to address the three core cognitive
tasks [26]. The use of interviews or specific capacity
measures alone does not give a practitioner informa-
tion about the presence or absence of impairment in
underlying cognitive abilities. It is for this reason that
physicians, lawyers, and others involved in DMC
evaluation should seek neuropsychological consult-
ation in complicated cases and cases where there are
questions about specific cognitive domains such as
memory or attention,
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Conclusions
Although the face validity associated with tools designed
to evaluate specific DMCs is appealing, questions remain
as to whether or not the degree of difficulty and test per-
formance can be generalized to a real-life situation [23].
Additionally, these kinds of instruments do not capture
the underlying cognitive abilities that subserve any given
capacity [23]. Therefore, in certain cases, neurocognitive
testing can and should be used to provide valuable add-
itional information for the DMC evaluation. Such two-
part evaluations involving a neuropsychological exam
and specific capacity-related inquiries is offered as a way
of increasing standardization, providing structure, and
limiting subjectiveness in the evaluation [3, 23]. While it
may be neither feasible nor desirable for every capacity
evaluation, it should be an approach for complicated
cases despite its inability to completely eliminate the
subjectiveness in DMC evaluation, which is never a
purely descriptive task but inherently involves normative
deliberation by the evaluating person [24].
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